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Purpose: To evaluate the relationship between myocardial infarction (MI) 
severity at magnetic resonance (MR) imaging and regional and 
global postinfarction left ventricular (LV) remodeling.
Materials and 
Methods:
This HIPAA-compliant study was institutional review board 
approved. In 186 patients, reperfused ST segment elevation 
MI (mean age 6 standard deviation, 59 years 6 11) was pro-
spectively studied the first week and 4 months after infarction. 
Microvascular obstruction (MVO) and intramyocardial hem-
orrhage (IMH) helped define three infarct severity groups: 
S0, no MVO or IMH (n = 68); S1, MVO, no IMH (n = 84); 
and S2, MVO and IMH (n = 34). Results were compared in 40 
control patients (mean age, 58 years 6 10). One-way analysis 
of variance or Kruskal-Wallis test with post hoc Bonferroni 
correction was used. Follow-up analysis was performed with 
paired Student t test or Mann-Whitney U test.
Results: Infarct severity was positively related (P , .001) to peak of 
troponin I, inflammatory biomarkers, area at risk, and infarct 
volume and inversely related to myocardial salvage ratio, sys-
tolic wall thickening (SWT) in the infarct, and adjacent myo-
cardium and LV ejection fraction (EF). At follow-up, LV EF 
significantly improved in S0 and S1 (S0: 53% 6 8 to 56% 6 
8, P , .001; S1: 48% 6 8 to 52% 6 10, P = .006), while S2 
adversely remodeled with increase in LV end-diastolic (175 
mL 6 35 to 201 mL 6 40) and end-systolic (100 mL 6 24 
to 115 mL 6 29) volumes (P , .001). SWT recovery in the 
infarct (S0: 32% 6 21 to 42% 6 24, P , .001; S1: 19% 6 13 
to 29% 6 19, P , .001; S2: 11% 6 9 to 15% 6 15, P = .22) 
and adjacent (S0: 41% 6 19 to 52% 6 21, P , .001; S1: 32% 
6 11 to 38% 6 16, P = .002; S2: 24% 6 13 to 29% 6 14, P 
= .092) and remote (S0: 54% 6 18 to 62% 6 20, P = .002; 
S1: 53% 6 18 to 57% 6 20, P = .092; S2: 50% 6 35 to 53% 
6 22, P = .75) myocardium was related to infarct severity. LV 
wall thinning with LV mass decrease occurred at follow-up 
(S0: 110 g 6 27 to 100 g 6 27, P , .001; S1: 115 g 6 24 to 
109 g 6 26, P = .019; S2: 134 g 6 35 to 117 g 6 27, P = .043).
Conclusion: MVO and IMH significantly affect postinfarct myocardial and 
LV remodeling; hemorrhagic infarcts behave worse than non-
hemorrhagic infarcts, with lack of functional recovery and 
adverse LV remodeling extending to remote myocardium.
q RSNA, 2014
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Advances in Knowledge
 n The presence of microvascular 
obstruction and/or intramural 
hemorrhage in patients with 
reperfused ST segment elevation 
myocardial infarction (MI) is as-
sociated with a greater degree of 
irreversible myocardial damage, 
as evidenced by cardiac bio-
markers (troponin I, S0: 31 mg/L 
[range, 13–60 mg/L]; S1: 86 mg/L 
[range, 52–151 mg/L]; and S2: 
191 mg/L [137–268 mg/L]; P , 
.001) and infarct volume (S0: 11 
mL 6 11; S1: 23 mL 6 14; and 
S2: 40 mL 6 19; P , .001) mea-
sured with late gadolinium-based 
contrast material–enhanced MR 
imaging.
 n Increasing infarct severity, as evi-
denced by the presence of micro-
vascular obstruction and/or 
intramural hemorrhage, is asso-
ciated with reduced global and 
regional LV function early 
postinfarction.
 n Increasing infarct severity, as evi-
denced by the presence of micro-
vascular obstruction and/or 
intramural hemorrhage, influ-
ences postinfarction regional and 
global LV functional recovery and 
LV remodeling.
Implications for Patient Care
 n Comprehensive cardiac MR im-
aging in acute myocardial infarc-
tion provides important informa-
tion with regard to infarct 
severity, allowing identification of 
patients with increased risk of 
adverse LV remodeling 
postinfarction.
 n The effect of myocardial necrosis 
in reperfused ST segment eleva-
tion MI is not limited to the 
infarct region but significantly 
affects the noninfarcted myocar-
dium, as well.
 n Persistent remote myocardial dys-
function at 4-month follow-up 
may be an early sign of evolution 
toward ischemic heart failure.
Early reperfusion therapy is the cur-rent standard of treatment in pa-tients with acute ST segment ele-
vation myocardial infarction (MI) (1). At 
the time of reperfusion, however, sub-
stantial myocardial necrosis has often 
occurred, and the process of irreversible 
myocardial damage is not necessarily 
ended by the restoration of the epicar-
dial coronary flow. Reperfusion itself can 
induce cardiomyocyte death (ie, myocar-
dial reperfusion injury). Moreover, many 
patients show microvascular obstruction 
(MVO) in the infarct region, caused by 
structural damage to the capillary bed, 
embolization of debris during the per-
cutaneous coronary intervention (PCI) 
procedure, and the release of vasocon-
strictor, thrombogenic, and inflamma-
tory substances (2–6). Moreover, in 
areas with severe MVO, extravasation of 
blood causes an intramyocardial hemor-
rhage (IMH) (7,8). Though myocardial 
infarct size is a major determinant of 
adverse left ventricular (LV) remodel-
ing and worse outcome, several studies 
have shown that MVO and IMH portend 
a worse prognosis (3–13).
Cardiovascular magnetic resonance 
(MR) imaging has become the modal-
ity of choice to study MI at different 
stages postinfarction (14). It allows for 
a comprehensive assessment of the re-
versible and irreversible tissue damage 
and a study of the effect on regional 
and global LV geometry and function 
(6,7,15,16). As it is obvious that MVO 
and IMH adversely affect postinfarc-
tion global LV remodeling, we hypothe-
sized that increasing infarct severity (as 
gauged with MVO and IMH) could have 
an effect on the noninfarcted myocar-
dium, which in turn yields global LV di-
latation and dysfunction. The objective 
of the present study was, therefore, to 
evaluate the relationship between in-
farct severity, as determined with MR 
imaging, and regional and global postin-
farction LV remodeling.
Materials and Methods
Patient Population
This prospective longitudinal study was 
undertaken in a single tertiary center. 
Patients with acute ST segment eleva-
tion MI were prospectively enrolled be-
tween December 2007 and July 2012. 
Patients were included if they were 
older than 18 years, had cumulative ST 
segment elevation of 6 mm or more, 
and were successfully treated with PCI 
within 12 hours after symptom onset 
and evidence of significant LV dysfunc-
tion (dyskinesia or akinesia involving 
three contiguous segments or more at 
echocardiography performed before 
MR imaging by independent experts). 
Exclusion criteria included previous 
MI or coronary revascularization, pul-
monary edema, cardiogenic shock, 
cardiomyopathy, estimated glomerular 
filtration rate less than 30 mL/min per 
1.73 m2, major comorbidities that limit 
life expectancy, or contraindications 
to MR imaging. No standard protocol 
was used for troponin and creatine 
kinase MB collection. Patients were 
studied in the first week and 4 months 
after the event. PCI and cardiac reha-
bilitation were performed according 
to guideline-based local practice, with 
early use of concomitant antiplatelet 
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and anticoagulant medications. To bet-
ter appraise the magnitude and im-
portance of observed functional and 
morphologic changes, patients with MI 
were compared with an age- and sex-
matched control group of patients with 
no evidence of coronary artery disease 
and absent late gadolinium-based con-
trast material enhancement (LGE) on 
MR images. Because of the exploratory 
nature of this study, no sample size cal-
culations were made prior to the onset 
of the study. Written informed consent 
was obtained for all subjects, and the 
study was approved by the ethics re-
view board of the University Hospital 
Leuven, Leuven, Belgium.
MR Imaging Protocol
Image acquisition was performed with 
a 1.5-T system (Intera; Philips Medical 
Systems, Best, the Netherlands) by us-
ing commercially available cardiac MR 
software, electrocardiographic trigger-
ing, and a cardiac-dedicated phase-ar-
ray coil. After determination of cardiac 
axes with localizers, LV function was 
assessed by using breath-hold steady-
state free precession cine MR imag-
ing (repetition time msec/echo time 
msec, 3.6/1.8; flip angle, 60°; section 
thickness, 8 mm; matrix, 160 3 256; 
field of view, 300 mm; pixel size, 1.6 3 
1.6 mm; and number of phases, 30). 
In cardiac short-axis direction, LV was 
completely encompassed by contigu-
ous sections. Next, T2-weighted MR 
imaging was performed in the cardiac 
short-axis direction by using a dark-
blood T2-weighted short-tau inver-
sion-recovery fast spin-echo sequence 
(repetition time, two heart beats; echo 
time, 100 msec; inversion time, 180 
msec; turbo factor, 33; matrix, 160 
3 256; field of view, 350 mm; section 
thickness, 8 mm; 8–10 contiguous sec-
tions) to assess the area at risk (AAR) 
and IMH. A breath-hold, T1-weighted, 
three-dimensional contrast material–
enhanced inversion-recovery gradient-
echo sequence (4.5/1.3; flip angle, 15°; 
20 contiguous sections; section thick-
ness, 5 mm; matrix, 128 3 256; field 
of view, 350 mm; pixel size, 1.4 3 1.4 
mm) was used to depict the presence of 
MVO and MI. An intravenous contrast 
material dose of 0.2 mmol of gado-
pentetate dimeglumine per kilogram 
of body weight was used. Presence 
and extent of MVO were evaluated in 
early imaging—that is, within the first 
5 minutes after contrast material ad-
ministration—while LGE imaging (after 
10–25 minutes) was used to evaluate MI 
extent. Inversion time was individually 
adapted to suppress the signal of nor-
mal myocardial tissue.
Forty age- and sex-matched sub-
jects (mean age 6 standard deviation, 
58 years 6 10; 34 men [85%] and six 
women [15%]) with clinical suspicion of 
coronary artery disease, in whom signif-
icant coronary artery disease was ruled 
out by means of fractional flow reserve 
measurement at invasive coronary an-
giography, were prospectively recruited 
at our center to undergo a similar MR 
imaging protocol as discussed earlier, 
including a first-pass stress perfusion 
sequence. Perfusion imaging consisted 
of three short-axis sections acquired 
every heartbeat. Rest imaging preceded 
stress by at least 10 minutes. Imag-
ing parameters were a balanced turbo 
gradient-echo sequence with 3/1.5; flip 
angle, 50°; 90° prepulse; 100-msec pre-
pulse delay; section thickness, 10 mm; 
and pixel size, 2.7 3 2.9 mm. For stress 
imaging, 140 mg/kg/min of adenosine 
was administered intravenously for ap-
proximately 4 minutes. Imaging com-
menced 3 minutes after starting the in-
fusion and continued until the end of the 
stress perfusion acquisition. For each 
perfusion study, a dose of 0.05 mmol/kg 
gadopentetate dimeglumine was used. 
An additional dose of 0.1 mmol/kg was 
administered for LGE imaging. The to-
tal administered dose in control patients 
and infarct patients was similar (ie, 0.2 
mmol/kg). To be considered as a control 
subject, first-pass perfusion findings had 
to be negative, with no evidence of myo-
cardial enhancement at LGE imaging.
Image Analysis
For all quantitative analyses, dedicated 
MR evaluation software was used (View-
Forum; Philips Medical Systems, Best, 
the Netherlands). Image analysis was 
performed by a single observer (J.B.) 
with more than 10 years of experience 
in cardiovascular MR imaging. For eval-
uation of global LV function and myo-
cardial mass, endocardial and epicar-
dial borders were manually traced in 
end-diastolic and end-systolic short-ax-
is sections. End diastole and end systole 
were defined as the largest and small-
est LV cavity, respectively, determined 
at the midventricular short-axis level. 
Papillary muscles and trabeculations 
were not included in the myocardium. 
End-systolic volumes were corrected 
for longitudinal shortening, excluding 
atrially located short-axis sections at 
end systole from analysis. Summation 
of delineated slides yielded LV end-di-
astolic volume (EDV) and end-systolic 
volume (ESV). LV ejection fraction (EF) 
was determined as the difference be-
tween LV EDV and LV ESV, divided by 
LV EDV and expressed as a percentage. 
Myocardial mass was obtained by multi-
plying myocardial volume by the specific 
density of myocardial tissue (ie, 1.05 g/
mL). To quantify regional myocardial 
morphology and function, a three-com-
partment approach (infarct, adjacent, 
remote) was performed by merging 
cine and LGE images, as described 
more extensively elsewhere (6,16). The 
location and extent of late myocardial 
enhancement was used to define the in-
farcted myocardium on the correspond-
ing short-axis cine MR images. The ad-
jacent periinfarct territory was defined 
by using an arbitrary angle of 30° on 
both sides of the infarcted myocardium 
on all sections, showing late myocardial 
enhancement (Fig 1). In the longitudinal 
ventricular direction on the first section 
of nonenhanced myocardium, the myo-
cardium in immediate contact with the 
enhanced myocardium was considered 
adjacent, as well, while the remaining 
myocardium was considered remote. 
By merging LGE and cine images, a 
single value of end-diastolic and end-
systolic wall thickness was obtained for 
all three compartments. Systolic wall 
thickening (SWT) was determined as 
the difference between end-systolic and 
end-diastolic wall thickness, divided 
by end-diastolic wall thickness and ex-
pressed as a percentage. Negative SWT 
values indicate compartments with sys-
tolic wall thinning.
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Figure 1
Figure 1: Midventricular short-axis LGE MR image (4.3/1.3, 
280-msec inversion time) obtained 12 minutes after contrast ma-
terial administration illustrates the three-compartment approach 
to divide the myocardium into an infarcted region, two adjacent 
(covering an angle of 30°) regions, and a remote region.
MI volume was determined on LGE 
images by using the extent of enhanced 
myocardium. MVO volume was deter-
mined in early postcontrast imaging 
by using the hypointense zone in the 
infarct-related myocardium. Both were 
measured by manually tracing the sus-
pected area on each short-axis section. 
When present, the zone of MVO was 
included in infarct volume estimation. 
Infarct transmurality was calculated as 
the ratio of mean thickness of enhanced 
myocardium to mean thickness of the 
corresponding myocardial wall. A sig-
nal intensity value of the myocardium 
supplied by the infarct-related artery 2 
standard deviations above the signal in-
tensity of remote myocardium was con-
sidered the AAR. IMH was defined as 
a hypointense area in the center of the 
AAR with a signal intensity 2 standard 
deviations below the signal intensity of 
the periphery of the AAR, having a min-
imal volume of 1 mL (1 cm3) (7). For the 
AAR calculations, the hemorrhagic area 
was included in the AAR. Myocardial 
salvage ratio was determined as infarct 
size at baseline, divided by the AAR at 
baseline and expressed as a percentage. 
Follow-up variation (D) of LV ESV was 
determined as the difference in LV ESV 
between follow-up and baseline, divided 
by LV ESV at baseline and expressed as 
a percentage. An DLV ESV percentage 
of at least 15% was considered to indi-
cate adverse LV remodeling at follow-up 
(17). Three groups of infarct severity 
were defined: Patients with no MVO 
or IMH were labeled S0, patients with 
MVO but without IMH were labeled S1, 
and patients with both MVO and IMH 
were labeled S2.
Statistical Analysis
Data were tested for normal distribution 
by using the Shapiro-Wilk test. Contin-
uous normally distributed data were ex-
pressed as means 6 standard deviations. 
Nonparametric data were expressed as 
median values with interquartile ranges. 
Categorical variables were expressed 
as frequency with percentage. For the 
infarct severity groups, continuous 
variables were compared by using the 
one-way analysis of variance or Kruskal-
Wallis test, as appropriate. When the 
results indicated presence of significant 
differences between groups, we made 
post hoc pairwise group comparisons by 
using the Student t test or Mann-Whit-
ney U test as appropriate, with Bonfer-
roni correction. A comparison between 
categorical variables was performed by 
using the x2 test or Fisher exact test, 
as appropriate. The Student paired t 
test or Wilcoxon test was used as ap-
propriate to compare continuous var-
iable differences between baseline and 
follow-up. A Spearman rank order cor-
relation was run to determine the rela-
tionship between changes in LV ESV and 
SWT in the infarcted myocardium. The 
distribution of SWT in the infarct region 
at 4 months was tested by means of one-
sample Kolmogorov-Smirnov analysis. 
Univariate linear regression analysis 
was performed to assess the variables 
associated with SWT in the infarct re-
gion at 4 months. Clinical and regional-
based variables with a significance level 
of P , .10 at univariate analysis were 
then introduced as covariates in the 
multivariate linear regression analysis to 
assess the independent determinants of 
SWT in the infarct region at follow-up. 
A two-sided P value of less than .05 was 
considered to indicate a significant dif-
ference. All analyses were performed 
with SPSS version 17.0 software (SPSS, 
Chicago, Ill).
Results
Patient Characteristics
Of 200 eligible patients, 14 patients 
were excluded because of refusal to 
participate (n = 3), loss during fol-
low-up (n = 4), or insufficient MR im-
age quality (n = 7). The remaining 186 
patients underwent MR imaging within 
1 week (median, 70 hours; interquar-
tile range, 47–96 hours) and 4 months 
after the acute event. During follow-up, 
six patients were readmitted because 
of recurrent angina (of which four un-
derwent PCI for restenosis), and five 
patients were hospitalized because of 
heart failure (four in the S0 group, four 
in the S1 group, and three in the S2 
group; P = .702). No cardiac deaths or 
reinfarction occurred during the first 
4 months postinfarction. By using the 
MR-based infarct severity classification, 
68 patients (36%) had no evidence of 
MVO or IMH (S0), 84 patients (45%) 
had MVO without IMH (S1), and 34 
patients (18%) had MVO and IMH 
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Figure 2
Figure 2: Cardiac short-axis MR images demonstrate increasing infarct severity. A, D, G, Short-axis T2-weighted short-tau inversion-recovery fast spin-echo im-
ages (two heart beats per 100 msec, 180-msec inversion time, 1.4 3 2.2-mm pixel size) were acquired. Gadolinium-based contrast material–enhanced MR images 
were obtained 15 minutes after contrast material administration (4.3/1.3) B, E, H, in the first week after infarction and C, F, I, at 4 months after infarction. The inver-
sion time was individually adjusted to suppress noninfarcted myocardium. A, B, C, The patient classified as S0 shows myocardial edema in the apical anteroseptal LV 
wall (arrows on A ) with 50% transmural enhancement after contrast material administration (arrows on B ). At 4-month follow-up, the initial infarct volume decreased 
from 16.7 mL to 8.6 mL (arrows on C ). D, E, F, The patient classified as S1 shows diffuse edema of the LV apex (arrows on D ). There is transmural enhancement (ar-
rows on E ) with a central zone of microvascular obstruction (∗ on E ). There was a decrease in infarct volume at 4-month follow-up, from 34.6 mL to 20.1 mL (arrows 
on F ). G, H, I, The patient classified as S2 shows myocardial edema in the lateral LV wall (arrows on G ) with a large central hypointense area, reflecting intramyocar-
dial hemorrhage (∗ on G ). After contrast material administration, transmural myocardial enhancement is present (arrows on H ) with large microvascular obstruction 
(∗ on H ). At follow-up, important thinning of the infarcted myocardium is found (arrows on I ), with decrease of the infarct volume from 66.5 mL to 33.1 mL.
(S2) (Fig 2). No significant differences 
in baseline variables were seen among 
the groups or with the control group 
(Table 1). Peak troponin I and creatine 
kinase MB values increased significantly 
(both P , .001) (Table 1) with increas-
ing infarct severity. No significant dif-
ferences in time from symptom onset 
to reperfusion or in culprit coronary 
artery distribution pattern were found 
between groups (Table 1).
LV Morphology and Function at Baseline
Increasing infarct severity was asso-
ciated with significantly larger AAR, 
greater infarct volume, and infarct 
transmurality but conversely with lower 
myocardial salvage ratios (all P , .001) 
(Tables 2, 3). The relative number of 
transmural infarcts increased with in-
creasing infarct severity—that is, 18% 
in S0, 24% in S1, and 65% in S2. When 
compared with end-diastolic wall thick-
ness in control patients, patients with 
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Table 1
Patient Characteristics
Parameter
Control  
Patients (n = 40) Patients (n = 186) P  Value S0 Group (n = 68) S1 Group (n = 84) S2 Group (n = 34) P  Value
Age (y)* 58 6 10 59 6 12 .66† 59 6 11 59 6 12 59 6 12 .99‡
No. of men 34 (85) 155 (83) .79§ 51 (75) 72 (86) 32 (94)|| .037§
No. of patients with arterial hypertension 16 (40) 60 (32) .48§ 24 (35) 22 (26) 14 (41) .23§
Body surface area (m2)* 1.92 6 0.17 1.92 6 0.20 .99† 1.90 6 0.22 1.94 6 0.20 1.94 6 0.16 .43‡
No. of patients with anterior MI NA 84 (45) NA 30 (44) 38 (45) 16 (47) .96§
Systolic blood pressure at  
 admission (mm Hg)*
130 6 23 132 6 22 .59† 131 6 24 133 6 21 132 6 24 .79‡
Diastolic blood pressure at  
 admission (mm Hg)*
74 6 13 77 6 13 .26† 76 6 14 77 6 13 77 6 13 .73‡
Peak creatine kinase MB level (U/L)# NA 212 (117–394) NA 120 (47–250) 215 (153–407)|| 384 (275–501)||** ,.001††
Peak troponin I level (mg/L)# NA 76 (31–147) NA 31 (13–60) 86 (52–151)|| 191 (137–268)||** ,.001††
Culprit coronary artery
 Left anterior descending coronary artery NA 86 (46.2) NA 31 (46) 40 (48) 15 (44) .93§
 Right coronary artery NA 83 (44.6) NA 33 (48) 37 (44) 13 (38) .61§
 Left circumflex coronary artery NA 17 (9.1) NA 4 (6) 7 (8) 6 (18) .14‡‡
Time to PCI (min)# NA 210 (150–318) NA 205 (150–304) 217 (148–308) 215 (169–377) .91§
Time between PCI and MR imaging (h)# NA 70 (47–96) NA 71 (48–96) 71 (48–96) 62 (46–77) .30§
No. of patients with medical treatment  
 at discharge
 Angiotensin-converting enzyme inhibitors  
 and/or angiotensin receptor blockers
4 (10) 172 (92) ,.001‡‡ 60 (88) 80 (95) 32 (94) .25§
 Beta-blockers 5 (12) 157 (84) ,.001‡‡ 56 (82) 73 (87) 28 (82) .70§
 Statins 7 (18) 172 (92) ,.001‡‡ 63 (93) 78 (93) 31 (91) .95§
 Antiplatelet agents 2 (5) 178 (96) ,.001‡‡ 65 (96) 81 (96) 32 (94) .85§
 Diuretics 1 (2) 135 (72) ,.001‡‡ 50 (74) 59 (70) 26 (76) .77§
Note.—Except where indicated, data are numbers of patients, with percentages in parentheses. To convert from units per liter to microkatals per liter, multiply by 0.0167. NA = not applicable.
* Data are means 6 standard deviations, unless indicated otherwise.
† Calculated with the Student t test.
‡ Calculated with one-way analysis of variance.
§ Calculated with the x2 test.
|| Bonferroni-adjusted P , .016 versus S0 group.
# Unless otherwise indicated, data are medians, with interquartile ranges in parentheses.
** Bonferroni-adjusted P , .016 versus the S1 group.
†† Calculated with the Kruskal-Wallis test.
‡‡ Calculated with the Fisher exact test.
infarct showed significantly higher 
end-diastolic wall thickness values not 
only in the infarcted region but also in 
the noninfarcted adjacent and remote 
myocardium (P , .001) (Table E1 [on-
line]). Conversely, SWT in patients 
with infarct was significantly less than 
in control patients (,.001 for all com-
parisons with control patients) (Fig 3). 
The impairment in SWT was most pro-
nounced in the infarcted region, but, 
to a lesser extent, was also detected in 
the adjacent and remote regions (P , 
.001 for all comparisons with control 
patients) (Fig 3). The severity of im-
pairment in SWT was positively related 
to infarct severity in the infarcted and 
adjacent myocardium (P , .001 for the 
difference between severity groups) 
(Fig 3). With increasing infarct se-
verity, LV EDV (P = .007), LV ESV (P 
, .001), and LV mass (P , .001) in-
creased, while LV EF (P , .001) de-
creased (Table 2).
Evolution of LV Morphology and Function
At follow-up, LV EF improved signifi-
cantly in the S0 and S1 groups (both P 
, .001), but not in the S2 group (Table 
2). On the contrary, the S2 group 
showed adverse LV remodeling with a 
significant increase in both LV EDV and 
LV ESV (both P , .001), an increase 
not present in the S0 and S1 groups 
(Table 2) (Fig 2). All groups showed a 
decrease in LV mass and a wall thin-
ning at follow-up (P , .001) (Table E1 
[online]). The latter was not limited 
to the infarct region but involved the 
adjacent and, to a lesser extent, the 
remote region, as well. In the infarct 
region, the magnitude of wall thinning 
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Table 2
LV Volumes, Mass, and Function in Patients and Control Patients
Parameter
Control 
Patients Patients P  Value S0 Group S1 Group S2 Group P  Value
LV EDV (mL)
 1 week 162 6 13 158 6 34 .18* 148 6 32 158 6 33 175 6 35†‡ ,.001§
 4 months … 167 6 41 .17* 153 6 32 166 6 40 201 6 40†‡ ,.001§
 P value … ,.001|| … .26|| .038|| ,.001|| …
LV ESV (mL)
 1 week 64 6 10 81 6 25 ,.001* 71 6 22 82 6 23† 100 6 24†‡ ,.001§
 4 months … 82 6 30 ,.001* 67 6 23 80 6 25† 115 6 29†‡ ,.001§
 P value … .96|| … .15|| .35|| .001|| …
LV EF (%)
 1 week 60 6 6 49 6 9 ,.001* 53 6 8 48 6 8† 43 6 8†‡ ,.001§
 4 months … 52 6 10 .030 56 6 8 52 6 10† 43 6 8†‡ ,.001§
 P value … ,.001|| … ,.001|| .006|| .51|| …
LV mass (g)
 1 week 99 6 24 117 6 28 ,.001* 110 6 27 115 6 24 134 6 35†‡ ,.001§
 4 months … 107 6 27 .09* 100 6 27 109 6 26 117 6 27† .009§
 P value … ,.001|| … ,.001|| .019|| .043|| …
Percentage DLV  
 ESV  15%#
NA 44 (25) NA 10 (15) 18 (23) 16 (50)†‡ ,.001**
Note.—Except where indicated, data are means 6 standard deviations. NA = not applicable.
* Calculated with the Student t test.
† Bonferroni-adjusted P , .016 versus the S0 group.
‡ Bonferroni-adjusted P , .016 versus the S1 group.
§ Calculated with one-way analysis of variance.
|| Calculated with the Student paired t test.
# Data are numbers of patients, with percentages in parentheses.
** Calculated with the x2 test.
was positively related to infarct sever-
ity. Partial functional recovery in SWT 
was present in the infarcted and ad-
jacent myocardium in the S0 and S1 
groups (both P , .01), but not in the 
S2 group (P = .22) (Fig 3). In the re-
mote myocardium, functional recovery 
was found in the S0 group (P = .002), 
a trend toward recovery was present 
in the S1 group (P = .09), and the S2 
group did not show improvement (P = 
.70) (Fig 3). Adverse LV remodeling oc-
curred more frequently in the S2 group 
(P , .001) (Table 2). Changes in LV 
ESV were inversely related to recovery 
in SWT (r = 20.284; 95% confidence 
interval: 20.415, 20.141).
Determinants of SWT in Infarcted 
Myocardium at Follow-up
The Shapiro-Wilk test for normality 
showed a normal distribution for SWT 
in the infarct region at follow-up (P = 
.39). At univariate linear regression 
analysis, male sex, greater end-diastolic 
wall thickness in the infarct region, in-
farct transmurality, and higher infarct 
severity at baseline were associated 
with lower SWT in the infarcted myo-
cardium at follow-up. On the other 
hand, a positive relationship was ob-
served between SWT of the infarct re-
gion at baseline and follow-up (Table E2 
[online]). Multivariate linear regression 
analysis showed that higher infarct se-
verity remained a significant predictor 
of lower SWT in the infarcted myocar-
dium at follow-up, even after correction 
for the other covariates, including in-
farct transmurality and SWT at base-
line (Table E3 [online]).
Discussion
In this study, we used comprehensive 
MR imaging to evaluate the effect of 
MVO and IMH on LV remodeling in the 
first 4 months postinfarction in 186 pa-
tients who underwent successful reper-
fusion of ST segment elevation MI. The 
major finding of our study is that infarct 
severity as assessed with cardiovascu-
lar MR imaging within 1 week of an ST 
segment elevation MI is associated with 
larger infarctions and is an important 
predictor of adverse LV remodeling 
Table 3
Infarct Characteristics at Baseline and Follow-up
Parameter Mean Value S0 Group S1 Group S2 Group P Value
Area at risk (mL)
 1 week 38 6 22 26 6 20 40 6 18* 56 6 21*† ,.001‡
Infarct volume (mL)
 1 week 22 6 17 11 6 11 23 6 14* 40 6 19*† ,.001‡
 4 months 11 6 9 6 6 7 12 6 8* 21 6 9*† ,.001‡
 P value ,.001§ ,.001§ ,.001§ ,.001§
Infarct volume/area at risk (%)
 1 week 57 6 26 42 6 23 61 6 25* 75 6 20*† ,.001‡
Infarct transmurality (%)
 1 week 77 6 18 63 6 15 82 6 13* 92 6 12*† ,.001‡
 4 months 68 6 19 52 6 12 73 6 15* 87 6 12*† ,.001‡
 P value ,.001§ ,.001§ ,.001§ .002§ ,.001‡
Note.—Unless indicated otherwise, data are means 6 standard deviations.
* Bonferroni-adjusted P , .016 versus the S0 group.
† Bonferroni-adjusted P , .016 versus the S1 group.
‡ Calculated with one-way analysis of variance.
§ Calculated with the Student paired t test.
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Figure 3
Figure 3: Box plots show systolic wall thickening in control patients and in the infarcted, adjacent, and remote myocardium in the different infarct severity groups 
at 1 week (white boxes) and 4 months (blue boxes) of follow-up. P values between infarct severity groups were calculated with one-way analysis of variance and the 
Student t test, as appropriate. P , .001 for the differences between severity groups in infarcted and adjacent myocardium. ∗ = Bonferroni-adjusted P , .016 versus 
the S0 group, # = Bonferroni-adjusted P , .016 versus the S1 group. P values between 1 week and 4 months were calculated by using the Student paired t test. 
White and blue circles represent outliers.
after 4 months. In addition, this LV re-
modeling process involves not only the 
infarcted myocardium, but also the ad-
jacent and remote myocardium.
Infarct Severity and LV Function
Our study results are consistent with 
previous data, showing that the presence 
of MVO, and, more importantly, IMH, is 
related to more extensive infarcts, as evi-
denced by cardiac biomarkers, AAR, and 
LGE burden (ie, infarct size and trans-
murality) (7,9,11). Since the distribution 
pattern of the culprit coronary artery 
and the time to reperfusion were similar 
between infarct severity groups, it can 
be questioned whether the phenome-
non of MVO and IMH itself contributes 
to a larger AAR and infarct volume. 
Moreover, myocardial salvage is in-
versely related to infarct severity (from 
nearly 60% in S0 to 25% in S2), empha-
sizing limited salvageable myocardium 
in hemorrhagic infarcts. Early postin-
farction, LV EF and SWT are inversely 
related to infarct severity. Patients with 
a hemorrhagic infarct show significantly 
larger LV EDV, not only in comparison to 
control patients but also with respect to 
S0 and S1 groups. This finding suggests 
an early onset of adverse LV remodeling 
in the hemorrhagic group. The effect of 
infarct severity on SWT early postinfarc-
tion is most obvious in the infarcted and 
adjacent myocardium. In the infarcted 
myocardium, this can be attributed to 
a greater infarct transmurality with in-
creasing infarct severity and to structural 
myocardial damage not limited to the 
myocytes but affecting the microcircula-
tion (in case of MVO), with additional 
interstitial extravasation of erythrocytes 
(in case of IMH). In the adjacent myo-
cardium, altered loading conditions and 
mechanical tethering of viable myocar-
dium adjacent to necrotic myocardium 
are likely mechanisms and can explain 
why the dysfunction increases with in-
creasing infarct severity (18,19). How-
ever, as we used LGE imaging to define 
the infarct region, stunned myocardium 
in the adjacent region may be another 
mechanism that causes dysfunction soon 
after infarction in the adjacent region. 
As such, it can be hypothesized that in 
less severe infarcts that show a higher 
myocardial salvage index, myocardial 
stunning prevails (or at least contributes 
to a larger extent), while in severe in-
farcts, tethering is the principal mecha-
nism of periinfarct dysfunction (20). Ad-
ditionally, this hypothesis could explain 
the divergence in functional recovery in 
the adjacent myocardium at follow-up, 
depending on infarct severity (see the 
following section).
In all patients with infarct, remote 
SWT was significantly impaired when 
compared with control patients, em-
phasizing that the noninfarcted myo-
cardium contributes to the decrease in 
LV EF. This finding is concordant with 
previous MR imaging studies (with or 
without MR tagging), showing remote 
myocardial dysfunction due to altered 
coronary vasodilatory properties, 
changes in regional mechanical load, 
and mechanical tethering to infarcted 
regions (18,21–23).
Patients with infarct show, in com-
parison to control patients, a significantly 
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higher wall thickness, inclusive of the 
noninfarcted remote myocardium. 
Whether this is a preexisting condition 
(eg, due to unrecognized arterial hyper-
tension in the infarct group) or reflects a 
so-called early LV remodeling due to an 
inflammatory response with interstitial 
fibrosis and edema, is unclear at the mo-
ment (24,25). Moreover, in the infarcted 
myocardium, infarct severity is associ-
ated with increase in LV wall thickness. 
This can be explained by more extensive 
myocardial damage, with increased cel-
lular swelling and interstitial edema in 
severe infarcts.
Infarct Severity and LV Remodeling
LV remodeling in the first months after 
infarction is significantly determined by 
infarct severity. Nonhemorrhagic infarcts 
improve LV function, while hemorrhagic 
infarcts do not recover functionally, but 
instead show adverse LV remodeling 
with significant increases in LV EDV and 
LV ESV at follow-up. At the myocardial 
level, a similar phenomenon is observed 
with partial functional recovery in the in-
farcted and adjacent myocardium in the 
nonhemorrhagic infarcts, which is not 
present in the hemorrhagic group. This 
divergence in functional recovery can be 
extended toward the remote myocar-
dium, with significant functional recovery 
in the S0 group, a trend toward func-
tional recovery in the S1 group, and lack 
of functional recovery in the S2 group. Al-
though the exact explanation for the lat-
ter phenomenon remains speculative (eg, 
inflammatory-mediated, reshaping of the 
left ventricle), it suggests that persistent 
remote myocardial dysfunction may be 
important in the evolution toward ische-
mic dilated cardiomyopathy. Structurally, 
a wall thinning is found at follow-up that 
is most pronounced in the infarcted myo-
cardium. The magnitude of wall thinning 
is the largest in hemorrhagic infarcts, 
which can be attributed to the more ex-
tensive myocardial damage (eg, greater 
infarct transmurality) being replaced by 
a thinner fibrotic scar (25,26).
Limitations
Some study limitations should be men-
tioned. First, we do not have prein-
farct data with regard to arterial blood 
pressures. This hampers a correct in-
terpretation with regard to the nature 
of the increased (remote) wall thick-
ness at baseline (preexisting hypertro-
phy as opposed to infarct-related re-
modeling). Second, we used dark-blood 
T2-weighted fast spin-echo sequences 
to assess IMH. Other study findings 
suggested that T2*-weighted sequences 
may be more sensitive in detecting IMH 
than T2-weighted sequences (27,28). 
Third, although we found LV remod-
eling to be related to infarct severity, 
this was not associated with increased 
mortality at 4-month follow-up. Longer 
follow-up is needed to evaluate whether 
patients with increased infarct severity 
have worse outcome, although the MR 
findings may lead to a more intensive 
antiremodeling therapy in patients with 
a severe infarct. Fourth, although, the-
oretically, the lack of improvement in 
SWT at follow-up in the S2 group could 
be related to the smaller sample size 
in this group, the regional findings are 
nicely in line with the lack of LV EF (P 
= .51) recovery in this group. Finally, 
since our study involved a single center, 
larger multicenter studies are needed 
to confirm our findings.
In conclusion, the presence of 
MVO and IMH has a significant effect 
on postinfarct myocardial and LV re-
modeling. In particular, hemorrhagic 
infarcts behave worse than nonhemor-
rhagic infarcts, with lack of functional 
recovery and adverse LV remodeling in-
volving the infarcted and noninfarcted 
myocardium.
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